Abstract:OBJECTIVE:To summarize the experience in diagnosis and surgical treatment of hepatic cholangiocarcinoma.METHODS:Clinical features, diagnosis, surgical treatment and prognosis of 52 patients with hepatic cholangiocarcinoma treated at our hospital from 1993 to 2001 were retrospectively reviewed.RESULTS:The patients with hepatic cholangiocarcinoma accounted for 4.1% (52/1261) of the total patients with primary liver carcinoma encountered at this hospital. The ratio of male to female was 1.36:1 in this group. Some patients were complicated by hepatitis B (32.7%), hepatolith (34.6%), liver abscess (13.5%), cirrhosis (53.8%), and serum positivity for alpha-fetaprotein (21.2%). No typical clinical manifestations were present in all patients. The diagnostic rates of ultrasound examination and CT were 80.8% and 94.2%, respectively. The resection rate of hepatic cholangiocarcinoma was 48.1%; and the 1-, 3-, 5-year survival rates were 48.1% (25/52), 30.8% (16/52), and 19.2% (10/52) respectively in this group. In resectable cases, the 1-, 3-, 5-year survival rats were 80.8% (20/25), 48.0% (12/25), 28.0% (7/25) respectively. Seven patients without cirrhosis who had received radical resection and intra-arterial chemotherapy survived for more than 5 years. In unresectable 27 cases, only 5 survived over one year even if selective hepatic arterial embolism and perfusion chemotherapy were employed.CONCLUSIONS:No specific serum marker is found for hepatic cholangiocarcinoma. CT diagnosis is superior to ultrasonography. When a patient has already diagnosed as having hepatolith or liver abscess before operation and occupying lesion is seen intraoperatively, rapid pathological examination should be done for a fair judgement of the nature of the mass and a decision-making of operative protocol. The patient can survive well after curative resection. No matter whether hepatic cholangiocarcinoma is resectable of not, both selective hepatic arterial embolism and perfusion chemotherapy are valuable.

DIAGNOSIS AND TREATMENT OF HEPATOLITHIASIS COMPLICATED WITH CHOLANGIOCARCINOMA:A REPORT OF 62 CASES

Clinicopathological features,diagnosis and treatment of hepatolithiasis complicated with cholangiocarcinoma

Primary hepatolithiasis complicating cholangiocarcinoma

Clinic Effect of Combination Use of Endoscopy and Laparoscopy in the Treatment of Cholecystoiithiasis and Extrahepatic Bile Duct Cholelithiasis

Laparoscopic Cholecystectomy Combined with Intraoperative Cholangiography and Endoscopic Sphincterotomy for the Treatment of Choledocholithiasis

Diagnosis and Treatment of Hepatic Cholangiocarcinoma: Report of 52 Cases.

Diagnosis and treatment of pancreatoiithiasis associated with peri-ampullary lesions

Laparoscopic cholecystectomy combined with intraoperative endoscopic sphincterotomy for acute cholangitis due to cholecystocholedocholithiasis

Laparoscopic Cholecystectomy in the Patients with Gallbladder Disease Combined with Hepatocirrhosis

Hepatocellular Carcinoma with Bile Duct Thrombi: Analysis of Surgical Treatment.

Surgical Treatment on Hepatocellular Carcinoma(HCC) with Bile Duct Tumor Thrombi

Imaging Diagnosis and Interventional Treatment for the Primary Hepatocellular Carcinoma with Biliary Obstruction

Total Laparoscopic Radical Resection for Bismuth Type Ⅲa Hilar Cholangiocarcinoma

Prognostic Factors of Hepatolithiasis With Cholangiocarcinoma

Successful Treatment of Colorectal Liver Metastasis Harboring Intrahepatic Cholangiocarcinoma

Diagnosis and treatment of choledocholithiasis by laparoscopy combined with cholangioscopy

Therapy of Cholelithiasis in Patients of Cirrhotic Portal Hypertension (CPH)

Evaluation of Surgical Approach for Extrahepatic Cholangiocarcinoma.

Peripheral cholangiocarcinoma associated with hepatolithiasis

Principles of diagnosis and treatment for hepatolithiasis

Diagnosis and Treatment of Primary Liver Cancer with Cancer Thrombus of the Bile Duct